Next Article in Journal
Not All Puppies and Sunshine: How Dog Keepers Cope with Dog-Related Problems in Dutch Society
Previous Article in Journal
HV1 mtDNA Reveals the High Genetic Diversity and the Ancient Origin of Vietnamese Dogs
Previous Article in Special Issue
Reasons for and Behavioral Consequences of Male Dog Castration—A Questionnaire Study in Poland
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Animals
Volume 13
Issue 6
10.3390/ani13061037
animals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Serotonin and Dopamine Blood Levels in ADHD-Like Dogs

by
Ángela González-Martínez
1,*,
Susana Muñiz de Miguel
1,
Noemi Graña
2,
Xiana Costas
3 and
Francisco Javier Diéguez
4
1
VTH Rof Codina, Santiago de Compostela University, 27002 Lugo, Spain
2
Lar do Belelle, Canine Center, 15509 Fene, Spain
3
Etoloxía, Behavior Medicine Service, 36312 Pontevedra, Spain
4
Anatomy, Animal Production and Clinical Veterinary Sciences Department, Santiago de Compostela University, 27002 Lugo, Spain
*
Author to whom correspondence should be addressed.
Animals 2023, 13(6), 1037; https://doi.org/10.3390/ani13061037
Submission received: 14 December 2022 / Revised: 6 March 2023 / Accepted: 8 March 2023 / Published: 13 March 2023
(This article belongs to the Special Issue Behavior and Physical Health Integration in Companion Animals)
Browse Figure
Review Reports Versions Notes

Abstract

:

Simple Summary

Attention deficit hyperactivity disorder (ADHD) is a relatively common neurodevelopmental disorder mainly affecting children and adolescents. ADHD is associated with significant social stigma, psychosocial adversities, and reduced working abilities. As with humans, dogs can suffer from ADHD-like behaviors, but to date, there are few studies on this condition in the canine species. Therefore, the present study analyzed the levels of serum serotonin and dopamine in dogs with signs that are similar to the ones presented in human patients with ADHD (compared to control dogs) that were assessed clinically and through different behavior scales. The results obtained indicate that both neurotransmitters have a tendency to be observed in lower concentrations in dogs presenting behavioral signs consistent with ADHD-like disorders. This finding may be useful for contributing to the study of the diagnosis and treatment of this disorder in dogs. ADHD-like associated behaviors can disrupt the normal coexistence of the dogs in their homes and contribute to abandonment, which continues to be a major social and animal welfare problem today.

Abstract

As with humans, dogs can suffer from attention deficit hyperactivity disorder-like (ADHD-like) behaviors naturally and exhibit high levels of hyperactivity/impulsivity and attention deficit problems, making the domestic dog a potential animal model for ADHD. ADHD has a very complex pathophysiology in which many neurotransmitters are involved, such as serotonin and dopamine. The aim of the study was to evaluate serum serotonin and dopamine levels in dogs with ADHD-like symptomatology. Fifty-eight dogs were studied, of which, thirty-six were classified as ADHD-like after physical and behavioral assessments. Additionally, the dogs’ owners performed a series of scientifically validated questionnaires which included C-BARQ, the Dog Impulsivity Assessment Scale, and the Dog-ADHD rating scale. Serum from every animal was collected after the behavioral assessments and analyzed with commercial ELISA tests for serotonin and dopamine determination. Kruskal–Wallis tests and Lasso regressions were applied to assess the relationships between both neurotransmitters and the ADHD-like behaviors (as assessed by clinical evaluation and through the different questionnaires). The dogs clinically classified as ADHD-like showed lower serotonin and dopamine concentrations. Further, serotonin and dopamine levels were also linked to aggression, hyperactivity, and impulsivity. Decreased serotonin concentrations were also related to fear, attachment, and touch sensitivity. Finally, it must be noted that our data suggested a strong relationship between serotonin and dopamine and ADHD-like behaviors.

1. Introduction

ADHD (attention deficit hyperactivity disorder) is one of the most frequently diagnosed syndromes in child psychiatry. The key symptoms (inattentiveness, impulsivity, and hyperactivity) deteriorate the relationships of these children both in their families and with other children, thus increasing the risk of social isolation [1]. The diagnostic and statistical manual of mental disorders (DSM-5) has established that these signs should be present for at least 6 months [2]. Furthermore, two-thirds of patients with ADHD diagnoses in childhood continue to have persistent, impairing symptoms in adulthood [3,4].
Neuroimaging studies have shown structural alterations in several brain regions in children and adults with the condition. The volumes of the accumbens, amygdala, caudate, hippocampus, putamen, and intracranial region were smaller in individuals with ADHD compared with the controls because of a delay in maturation. These data confirm that patients with ADHD have altered brains and, therefore, ADHD is a brain disorder and a relevant model of a disorder of brain maturation delay [4,5,6,7].
As with humans, dogs can suffer from ADHD-like behaviors naturally and manifest high levels of hyperactivity/impulsivity and attention deficit problems, making the domestic dog a highly potential animal model for ADHD [8,9,10].
ADHD is a very complex pathophysiologic disorder in which many neurotransmitters are involved. GABA, glutamate, histamine, serotonin, and dopamine are involved in different ways in ADHD. ADHD has been associated with dopamine dysfunction in the mesocortical, mesolimbic [11], and nigrostriatal pathways [12]. Disturbances in the mesocortical dopamine pathway are thought to give rise to cognitive deficits. The mesocortical pathway has dopamine cell bodies in the ventral tegmental area (VTA) with projections via the medial forebrain bundle to the frontal cortex. As such, it acts as an important regulator of cognitive functioning. Disturbances in the mesolimbic pathway are thought to cause motivational deficits in ADHD. The mesolimbic dopamine pathway forms a crucial part of the brain “reward” circuits. Here, fibers from the VTA project via the medial forebrain bundle to discrete parts of the limbic system, especially to the nucleus accumbens [11]. Finally, the dopaminergic nigrostriatal pathway has projections from the substantia nigra to the striatum and plays a critical role in dopamine signaling [13], particularly, that involved in cognitive and voluntary movement control [14].
Methylphenidate, a stimulating drug, inhibits the presynaptic uptake of dopamine. Approximately 70% of children and adolescents with ADHD respond positively to stimulating treatment [1,15], and it seems that some ADHD-like dogs also respond to this therapy [16,17]. Some genetic markers for the dopamine system are found in humans [1,18] and dogs. Thereby, polymorphism in the tyrosine hydroxylase gene is associated with activity-impulsivity in German Shepherd dogs [19]. Likewise, DRD4 exon 3 polymorphism is associated with significantly higher scores in the activity-impulsivity dimension of a dog-ADHD rating scale in police German Shepherds [20]. Thus, dopamine dysfunction has been strongly related to ADHD pathophysiology.
Nevertheless, approximately 30% of ADHD humans cases are ‘non-responders’ to the first line of treatment, i.e., methylphenidate or amphetamine [21]. Studies of animal models of ADHD indicate an intimate interplay between serotonin and dopaminergic neurotransmission. Serotonin behavioral effects are complex and unspecific. Serotonin plays a role in the regulation of mood, eating control, sleep, arousal, and pain regulation [22]. Markedly, serotonin regulates dopamine transmission via multiple serotonin receptors [23], and therefore, it is plausible that a serotonin disturbance could also contribute to ADHD-associated behavioral and cognitive impairments in part via its action on dopamine. Different gene polymorphisms that modulate the expression of serotonin transporters and serotonin receptors which, in turn, modulate extracellular serotonin levels have been found to increase the susceptibility to ADHD [14]. Drugs that inhibit the reuptake of serotonin are prescribed in the treatment of different mental illness such as depression, anxiety disorders, and obsessive-compulsive disorder [22]. Selective serotonin re-uptake inhibitors and non-stimulant drugs acting on the serotonin system are, however, clinically effective for treating ADHD [24]. Further, in dogs, fluoxetine was useful and well tolerated in treating ADHD-like behaviors [25,26,27].
In neurocognitive models of ADHD, ‘inhibition’ is considered to be a core deficit that is mediated by serotonin [24,28]. Previous studies have indicated a decrease in blood serotonin levels among hyperactive and ADHD children [24,29,30]. In fact, a chronic deficiency in available serotonin may contribute to the clinical symptoms of ADHD [31]. Interestingly, lower levels of urine serotonin and dopamine were found in dogs with higher impulsivity [32]. In addition, aggressive and impulsive dogs showed lower levels of blood serotonin [33,34,35,36]. Nevertheless, there are no previous studies assessing serotonin or dopamine levels in ADHD-like dogs.
Therefore, the aim of the present study was to evaluate serum serotonin and dopamine levels in ADHD-like dogs (vs control dogs) as assessed by clinical evaluation and in dogs assessed through different validated questionnaires.

2. Materials and Methods

2.1. Surveyed Animals and Data Collection

The study was carried out at the Rof Codina Veterinary Teaching Hospital (VTHRC), which is part of the Veterinary Faculty of Lugo (the referral center for veterinary clinics in northwest Spain), with the collaboration of two other leading behavioral medicine services, Lar do Belelle and Etoloxía, also in northwest Spain. A total of 58 dogs were included in the study. They were recruited through cases that came to behavioral medicine services because of hyperactivity, impulsivity, or attention deficit problems and through an active search of dogs with ADHD-like signs, and the control dogs were recruited through social media networks such as Facebook, Instagram, and LinkedIn. We also shared an e-mail chain, starting with our personal contacts. Therefore, 40 of the 58 dogs had attended consultation at the VTH RC, with 10 at the Lar do Belelle center and 8 at the Etoloxía center. During consultation, we collected data on gender, entire or neutered, age (months), age at acquisition (months), weight (kg), activity pattern (whether the dog performed some activity such as agility, dog jogging, dog trekking, dog biking, mushing, or other), whether the owner had had other dogs previously, and habitat (rural or urban). Evaluations of the dogs were carried out by a veterinarian specializing in behavioral medicine.

2.2. Dog Assessment

As mentioned, all the dogs were examined by a veterinarian specializing in behavioral medicine. A complete history and behavioral and physical examinations (with the collection of blood samples) was carried out. ADHD-like were suspected in cases that presented hyperactivity, impulsivity, or attention deficit symptoms (a list of different symptoms of the ADHD-like dogs are described in Table 1) [8,25,37].
Based on the above and on the Canine Behavioral Assessment and Research Questionnaire (C-BARQ) [38,39,40], 5 dogs with suspected attention deficit related to phobias, hyperactivity that could be associated with a lack of exercise, and impulsivity that could originate from previous learnings, as well as patients with organic pathologies (including chronic pain), were not included in the final sample of 58 animals.
In addition, all the dogs’ owners completed a series of scientifically validated questionnaires in addition to the C-BARQ: Dog Impulsivity Assessment Scale (DIAS) [41,42] and the Dog-ADHD rating scale, owner’s version [8].
The C-BARQ questionnaire consists of 100 questions describing the different ways in which dogs typically respond to common events, situations, and stimuli in their environments. Responses are grouped into 14 behavioral traits: stranger-directed aggression, owner-directed aggression, dog-directed aggression, dog-directed fear, familiar dog aggression, trainability, chasing, stranger-directed fear, nonsocial fear, separation-related problems, touch sensitivity, attachment/attention seeking, excitability, and energy. All traits are expressed on a 0 to 4 scale in which 0 indicates no sign of such behavior and 4 indicates a severe form of the behavior.
The DIAS is an owner-based questionnaire with 18 statements concerning their perceptions of the behavioral tendencies of their dog, with individual item responses scored on a 1–5 scale. The scores were calculated for the overall questionnaire (OQS) and for each of the three subscales that compose it: “Behavioural Regulation”, “Aggression & Response to Novelty”, and “Responsiveness” [32,41,42,43].
The Dog-ADHD rating scale, owner version (Dog ARS) was developed on the basis of a validated human ADHD questionnaire. In the Dog ARS, six items are designed to refer to attention deficits in a dog (Subscale I) and seven are designed to measure the level of motor activity and impulsivity (Subscale II). The owners have to choose answers from the presented alternatives representing different frequencies of how often the statement is true for their dog on a four-level scale (never, rarely, often, or very often) [8].
The dogs were treated according to the European and Spanish legislation on animal protection (Directive 86/609/EEC, Real Decreto 1201/2005), and the Ethical Committee of the VTH Rof Codina approved the experiments and procedures.

2.3. Serotonin and Dopamine Measurement

Serum from every animal was collected after the behavioral assessment. Blood samples were obtained by venipuncture using tubes without anticoagulant from the jugular, cephalic, or saphenous vein. After that, they were centrifuged and frozen at −80 °C until analysis.
The serum samples were analyzed with two commercial ELISA tests (the Serotonin High Sensitive ELISA, DLD Diagnostika GMBH, Hamburg, Germany), and the Canine Dopamine DA ELISA Kit, MyBioSource, San Diego, CA, USA). These are competitive ELISA kits for the quantitative determination of serotonin and dopamine, respectively.
The analyses were performed following the recommendations and procedures indicated by the manufacturer for serum samples. According to the test, concentrations were expressed in ng/mL.

2.4. Statistical Analyses

Statistical analyses were performed using R Statistical Software (Supplementary Table S1). Initially, the scores obtained for the studied animals in the different traits for the DIAS, Dog ARS, and C-BARQ questionnaires were transformed into binary variables, taking as cut-off points for each trait the median of the study population for that trait. This allowed for dividing the population into two groups of similar sizes. Subsequently, the differences in the serotonin and dopamine concentrations for the suspected ADHD dogs, based on the behavioral examinations (yes/no) and the different DIAS, Dog ARS, and C-BARQ tests (scores under or over the median), were examined by Kruskal–Wallis tests.
Finally, a Lasso regression (glmnet package, https://cran.r-project.org/web/packages/glmnet/index.html, accessed on 28 June 2021) was applied to evaluate the effects of serotonin and dopamine levels on the suspected diagnosed ADHD dogs (yes/no) and the different DIAS, Dog ARS, and C-BARQ tests (as mentioned, and transformed into the binary variables of scores above or over the median). Gender, reproductive status (entire or neutered), age (months), age at acquisition (≤2 months or >2 months of age), weight (kg), activity pattern (whether the dog performed some activity such as agility, dog jogging, dog trekking, dog biking, mushing, or other), whether the owner had had other dogs previously, and habitat (rural or urban) were also included in the models as independent control variables. One model was performed for the ADHD-like suspected symptoms and one for each DIAS, Dog ARS, and C-BARQ test.
A K-fold cross-validation was performed to determine the lambda value that produced the lowest test mean squared error. The main advantage for the Lasso regression was that the model performed automatic feature selection to decide which variables should and should not have been included on their own. It helps to reduce overfitting and it is useful for variable selection when there are several independent variables that may not contribute to the outcome.

3. Results

After the behavioral examinations, 36 of the 58 dogs (62.0%) were classified as ADHD-like (presenting hyperactivity, impulsivity, or attention deficit symptoms). The remaining ones were used as control dogs (no ADHD-like symptoms). Descriptive features of the studied population (total and stratified by ADHD-like diagnosis) are shown in Table 2.
The mean serotonin and dopamine serum concentrations in the dogs with suspected diagnoses as being ADHD-like (vs the not suspected ADHD-like dogs) and the dogs with scores over and under the median for the different DIAS, Dog ARS, and C-BARQ traits evaluated are provided in Table 3. In the univariate approach (Kruskall–Wallis test), the differences between the groups for the serotonin serum concentrations were significant for the suspected ADHD-like dogs, the DIAS total score, the DIAS behavioral regulation score, the DIAS aggression score, the Dog ARS activity-impulsivity score, and the C-BARC owner-directed aggression, dog-directed fear, and non-social fear scores. In the case of dopamine, significant differences were observed for the dogs with a suspected diagnosis for being ADHD-like, for the ARS activity-impulsivity score, and for the C-BARC energy score. The p-values obtained from the Kruskall–Wallis test are provided in Appendix A. Box diagrams of the serotonin and dopamine levels for the dogs with suspected diagnoses of being ADHD-like (vs. the control dogs) and the dogs with scores over and under the median for the different DIAS, Dog ARS, and C-BARQ traits are shown in Figure 1.
The multivariate Lasso regression indicated that the dogs with lower serotonin and dopamine serum concentrations were more likely to be diagnosed as being ADHD-like. The results also suggested that gender, neuter status, and age were significant contributors to the prevalence of ADHD-like symptoms (with higher odds in male, entire, and younger dogs) (Table 4).
Regarding the total DIAS score, dogs with lower serotonin and dopamine serum concentrations were more likely to have scores over the median, aside from males and entire animals. In relation to behavioral regulation, it varied with serotonin concentrations in the same direction as the total DIAS score; the model also indicated that the behavioral regulation scores increased with decreased age. Finally, serotonin and dopamine levels were also linked to aggression, aside from gender, dog activity pattern, and number of dogs previously owned (with male dogs being more likely to have DIAS aggression scores over the median, whereas dogs that performed some activity or dogs whose owners who had previously had dogs were more likely to have scores under the median) (Table 4). No relationship was found between serotonin or dopamine concentration and responsiveness.
Data from the Dog ARS activity-impulsivity indicated that dogs with lower serotonin serum concentrations were more likely to have scores over the median (Table 4). No relationship was found between serotonin or dopamine concentration and Dog ARS inattention.
No relationships were found between serotonin and dopamine serum concentrations and trainability, stranger-directed aggression, owner-directed aggression, dog-directed aggression, stranger-directed fear, separation-related problems, and excitability, as measured by the C-BARQ.
However, the probability of a score being over the median for dog-directed fear increased with decreased serotonin concentrations. It also increased in males, entire animals, animals acquired at less than 2 months old, and those whose owners had no dogs previously. With regard to rivalry, the regression model indicated that dogs with lower serotonin had higher C-BARQ scores; higher scores were also found for females and entire animals. Lower serotonin levels likewise increased the scores for non-social fear and touch sensitivity. Touch sensitivity was also higher in dogs acquired at less than 2 months of age, and it increased as weight decreased. Serotonin concentration was also related to attachment (higher scores at lower concentrations). Further, attachment scores were higher in males and with increasing weight and lower in active dogs. Finally, energy scores were higher in animals with lower dopamine levels and in younger dogs (Table 5).

4. Discussion

In humans, ADHD may be associated with dysregulation of the catecholaminergic and serotonergic systems [30]. Moreover, several studies have shown a decrease in serum serotine in ADHD patients [1,29,30,43]. As in human studies, we found that serotonin and dopamine levels were significantly lower in suspected ADHD-like dogs.
One limitation of the study was the possible ADHD-like diagnosis subjectivity. Because of the lack of a gold standard test, it was based on the behavior signs of being ADHD-like. Nevertheless, three validated questionaries were also used. C-BARQ was used to help in the diagnosis of different behavior problems. Furthermore, the relationships between dopamine, serotonin, and the C-BARQ were not based on the clinical subjective diagnosis. In the same way, the Dog ARS is a validated scale that was developed on the basis of a validated human ADHD questionnaire [8], and the DIAS is a validated owner-based questionnaire used to assess impulsivity [32,41,42]. The use of these different scales allowed us to identify a more objective relationship between the different traits and neurotransmitters.
Regarding the serotonergic system, it was previously thought that dopamine is the key regulator of hyperactivity, but research findings from rodent and hamster models have suggested that serotonin is also involved in hyperactivity [24,44,45,46]. Furthermore, several human and animal studies have indicated a link between poor impulse control and a low level of the major serotonin metabolite 5-hydroxyindolacetic acid in cerebrospinal fluid [30]. ADHD patients with oppositional defiant disorder (the most frequent coexisting condition in ADHD, characterized by a repeatable pattern of negativistic and defiant behavior) showed lower serum serotonin levels than pure ADHD patients. Furthermore, some tricyclic anti-depressants, as well as monoamine oxidase inhibitors, which are known to increase serotonergic activity, are apparently efficacious in reducing hyperactivity, impulsiveness, and concentration impairment in ADHD children [30,47].
There are few studies related to impulsivity and serotonin in dogs. The DIAS was previously used to assess urine serotonin and dopamine in impulsive and control dogs. Higher DIAS impulsivity scores were found to be significantly correlated with impulsive behavior (reduced tolerance to delay of reinforcement) and lower levels of urinary serotonin and serotonin/dopamine ratios [32]. Further, Peremans et al. [48] supported the role of the serotonergic system in canine impulsive aggression. Similar results were found in the present study in which dogs with higher DIAS scores showed lower serotonin concentrations. Moreover, the other impulsivity-hyperactivity scale used in this study, the Dog ARS, also related impulsivity-hyperactivity scores with lower serotonin levels. In this line, the clinical effectiveness of fluoxetine, a selective serotonin re-uptake inhibitor, in the treatment of ADHD-like dogs [25,26,27] could be linked with the serotonin effect on impulsivity, hyperactivity, and with the intimate interplay between serotonin and dopaminergic neurotransmission [24].
ADHD is frequently associated with comorbid aggression [14], anxiety, and phobias [49,50,51]. Furthermore, ADHD- like dogs have had strong comorbidities with compulsive behaviors, aggressiveness, and fearfulness [52]. A strong relationship between aggression and low serotonin levels has been demonstrated in different species, including dogs [33,34,36]. Similar results were found in the present study where different aggression scales were related to serum serotonin. The Lasso regression indicated that the dogs with lower serotonin levels were more likely to have scores over the median for the DIAS subscale of aggression and for the C-BARQ rivalry behavioral trait. In relation to the above, the aggressive dogs showed low serotonin levels; however, aggression is one of the symptoms and comorbidities of being ADHD-like precisely because of the tendency to behave impulsively, and it is also related to low serotonin levels. Serotonin likely mediates the tendency to behave aggressively and impulsively in ADHD-like dogs.
Animal models consistently demonstrate that brain serotonin systems are critically involved in the response to stressors, as well as in fear and anxiety generation [53,54,55]. Accordingly, lower serotonin concentrations have been found in dogs showing defensive forms of aggression than in other aggression forms [33], and serotoninergic drugs are used to treat fear and phobias in humans [56,57] and dogs [58,59]. Interestingly, in the present paper, significantly lower serotonin levels were found in the dogs with higher C-BARQ scores for fear, anxiety, and touch sensitivity, and touch sensitivity is related to fearful or wary responses to potentially painful or uncomfortable procedures. Moreover, previous research has shown the relationship between serotonin and attachment. In this sense, early maternal deprivation is related to decreasing 5-hydroxyindoleacetic levels in the cerebrospinal fluid and/or through changes in serotonin transporter gene DNA methylation [60,61,62]. Nevertheless, the association between blood serotonin and attachment in dogs was not previous described. Although the importance of serotonin in the social behaviors of different species has already been studied, is still needed to clarify the relationship between blood serotonin and attachment in dogs.
Since approximately 70% of the children and adolescents with ADHD successfully respond to methylphenidate [1,15] and some ADHD-like dogs respond to this treatment as well [16,17], it appears that dopamine has an important role in ADHD. Some genes of the dopaminergic neurotransmitter system were associated with activity, impulsivity, and attention deficits in dogs [19,20,63,64]. Nevertheless, this is the first study that showed a relationship between ADHD-like dogs and serum dopamine. More specifically, it appeared that the dogs with high activity scores were more likely to show lower dopamine levels. Dopamine functions are related to voluntary movement. Therefore, studies on hamsters indicated that Rovorowsky hamsters (which are more hyperactive than Djungarian hamsters) had lower levels of brain dopamine [45].
No relationship was found between serotonin or dopamine concentration and attention deficits. Furthermore, police German Shepherd dogs (possessing polymorphism in exon 3 of the dopamine D4 receptor gene) showed significantly higher scores in the activity-impulsivity component of the dog-ADHD rating scale than did dogs without this allele. This relationship was not found for the attention deficit component [20]. More studies appear to be necessary in order to deepen the relationship between attention deficits and dopamine and serotonin levels, or perhaps the serum levels of dopamine and serotonin may not be good markers for studying attention deficits.
A higher incidence of human ADHD is described in boys (compared to girls) [1,2]. Comparable results were found in our study where males suffered from being ADHD-like significantly more frequently than females, aside from having higher DIAS scores. Previous research has found similar risk factors for dogs [37,65]. In addition, neutering appeared to be an important risk factor for being ADHD-like, and entire animals were more prone to suffering ADHD-like behaviors than castrated dogs and had higher DIAS scores, as previously described [37,65]. Nevertheless, Zink et al. [66] found that neutering could be a risk factor for hyperactivity, whereas Fadel et al. [67] indicated that castrated animals showed higher DIAS scores. Nevertheless, some owners could try to find a solution for dealing with the condition of their dog by neutering. Hence, the role of sex hormones in ADHD-like behaviors should be studied in more detail.
Interestingly, age was also a significant contributor to the prevalence of ADHD-like symptoms. Furthermore, the DIAS behavior regulation score increased with decreasing age. Other studies have found that hyperactive, impulsive, and inattentive behaviors were much more prevalent in young dogs [9,19,41,65]. Likewise, in humans, ADHD is age-dependent, being more prevalent in youths [4], in spite of the possibility that the condition can remain present in adult humans. Young dogs may appear more hyperactive to inexperienced owners; however, the possible effect of age was used as a control variable in the multivariate analysis.
Dogs that performed some activity and dogs from owners who had previously had dogs were more likely to have scores below the median for DIAS aggression. Other studies observed associations between an owner’s dog experience and a dog’s aggressive behavior [52,54,55,56,57,68,69,70]. It is possible that experienced owners are more aware of the importance of socialization. Previous experience can also help owners to identify a problem at an early stage, when the problem can be treated more efficiently. Furthermore, if the owners had problems with their first dogs, they may be more careful when choosing a new dog [52]. On the other hand, they could have a comparison point if the previous dog was behaving normally. Hence, they might be more aware that something is not normal and refer to it earlier. In addition, they might have more experience in dog training, which could be a part of the improvement in their dog.
Activity patterns had a relationship with the presence of aggression. The complete underlying mechanism behind the effect of exercise in aggression is not clear, but it is known that exercise increases serotonin production both in animals and humans, thus functioning as an antidepressant [71], and it was also related to reduced anxiety [72] and aggression in dogs [70]. In addition, in ADHD-like cases, owners might have difficulties in walking or exercising their dogs. Consequently, the quantity of exercise might be a consequence of the dog being challenging for months, rather than a correlation or a cause.
Finally, the paper highlights the importance of pairing assessments by veterinary specialists using validated tests with avoiding assessments by other professionals. Further, it would be interesting to assess the role of genetics and neurotransmitters in ADHD-like dogs in future studies.

5. Conclusions

Our data suggest a strong relationship between serotonin and dopamine and ADHD-like dogs. Furthermore, lower serotonin and dopamine serum concentrations were related to being ADHD-like. Moreover, serotonin and dopamine levels were also linked to aggression, activity, and impulsivity. Decreased serotonin concentrations were also related to fear, attachment problems, and touch sensitivity.
No relationship was found between serotonin and dopamine serum concentrations and attention deficits.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ani13061037/s1, Table S1: Study data set.

Author Contributions

Conceptualization, Á.G.-M. and S.M.-d.M.; methodology, Á.G.-M., S.M.-d.M., F.J.D., X.C. and N.G.; software, F.J.D.; validation, Á.G.-M., S.M.-d.M. and F.J.D.; formal analysis, F.J.D.; investigation, Á.G.-M., S.M.-d.M., X.C., N.G. and F.J.D.; resources, F.J.D.; data curation, Á.G.-M. and F.J.D.; writing—original draft preparation, Á.G.-M. and F.J.D.; writing—review and editing, Á.G.-M., S.M.-d.M. and F.J.D.; visualization, Á.G.-M., S.M.-d.M. and F.J.D.; supervision, Á.G.-M.; project administration, Á.G.-M. and F.J.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Fundación Rof Codina (protocol code AELU001/21/INVMED(2)/ANIMAL(05)/AGM/01, date of approval 28 June 2021).

Informed Consent Statement

Informed consent was obtained from all the dogs’ owners involved in the study.

Data Availability Statement

The data presented in this study are available on request from the first author/corresponding authors.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table
Table A1. The p-values obtained from the Kruskal–Wallis tests used to compare the mean serotonin and dopamine serum concentrations (ng/mL) in the dogs with a suspected diagnosis of being ADHD-like (vs. not ADHD-like dogs) and the dogs with scores over and under the median for the different DIAS, Dog ARS, and C-BARQ traits are shown in Table A1.
Table A1. The p-values obtained from the Kruskal–Wallis tests used to compare the mean serotonin and dopamine serum concentrations (ng/mL) in the dogs with a suspected diagnosis of being ADHD-like (vs. not ADHD-like dogs) and the dogs with scores over and under the median for the different DIAS, Dog ARS, and C-BARQ traits are shown in Table A1.
Serum Serotonin Concentration (95% CI)Serum Dopamine Concentration (95% CI)
ADHD-like0.030.016
DIAS total score0.0050423
DIAS behavioral regulation score0.010.233
DIAS responsiveness score0.5230.119
DIAS aggression score0.0020.970
Dog ARS activity-impulsivity score0.0120.011
Dog ARS inattention score0.4350.563
C-BARQ trainability0.8690.443
C-BARQ stranger-directed aggression0.3160.538
C-BARQ owner-directed aggression0.0430.154
C-BARQ dog-directed aggression0.2720.836
C-BARQ dog-directed fear0.0040.593
C-BARQ rivalry0.1760.676
C-BARQ chasing0.2120.469
C-BARQ stranger-directed fear0.2570.927
C-BARQ nonsocial fear0.0230.428
C-BARG separation-related problems0.9610.157
C-BARQ sensitivity0.1320.686
C-BARQ excitability0.1040.599
C-BARQ attachment0.1400.142
C-BARQ energy0.5600.040

References

  1. Paclt, I.; Koudelová, J.; Křepelová, A.; Uhlíková, P.; Gazdíková, M.; Bauer, P. Biochemical Markers and Genetic Research of ADHD. Neuroendocrinol. Lett. 2005, 26, 423–430. [Google Scholar] [PubMed]
  2. Morrison, J. DSM-5® Guía para el Diagnóstico Clínico; Editorial El Manual Moderno: Mexico City, Mexico, 2015. [Google Scholar]
  3. Faraone, S.V.; Biederman, J.; Spencer, T.J.; Aleardi, M. Comparing the Efficacy of Medications for ADHD Using Meta-Analysis. Medscape Gen. Med. 2006, 8, 4. [Google Scholar]
  4. Hoogman, M.; Bralten, J.; Hibar, D.P.; Mennes, M.; Zwiers, M.P.; Schweren, L.S.J.; van Hulzen, K.J.E.; Medland, S.E.; Shumskaya, E.; Jahanshad, N.; et al. Subcortical Brain Volume Differences in Participants with Attention Deficit Hyperactivity Disorder in Children and Adults: A Cross-Sectional Mega-Analysis. Lancet Psychiatry 2017, 4, 310–319. [Google Scholar] [CrossRef] [Green Version]
  5. Xavier Castellanos, F.; Lee, P.P.; Sharp, W.; Neal Jeffries, M.O.; Greenstein, D.K.; Clasen, L.S.; Blumenthal, J.D.; Regina James, M.S.; Ebens, C.L.; James Walter, B.M.; et al. Developmental Trajectories of Brain Volume Abnormalities in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. JAMA 2002, 288, 1740–1748. [Google Scholar] [CrossRef] [Green Version]
  6. Hoogman, M.; Rijpkema, M.; Janss, L.; Brunner, H.; Fernandez, G.; Buitelaar, J.; Franke, B.; Arias-Vásquez, A. Current Self-Reported Symptoms of Attention Deficit/Hyperactivity Disorder Are Associated with Total Brain Volume in Healthy Adults. PLoS ONE 2012, 7, e31273. [Google Scholar] [CrossRef] [PubMed]
  7. Shaw, P.; Gilliam, M.; Liverpool, M.; Weddle, C.; Malek, M.; Sharp, W.; Greenstein, D.; Evans, A.; Rapoport, J.; Giedd, J. Cortical Development in Typically Developing Children with Symptoms of Hyperactivity and Impulsivity: Support for a Dimensional View of Attention Deficit Hyperactivity Disorder. Am. J. Psychiatry 2011, 168, 143–151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Vas, J.; Topál, J.; Péch, É.; Miklósi, Á. Measuring Attention Deficit and Activity in Dogs: A New Application and Validation of a Human ADHD Questionnaire. Appl. Anim. Behav. Sci. 2007, 103, 105–117. [Google Scholar] [CrossRef]
  9. Lit, L.; Schweitzer, J.B.; Iosif, A.M.; Oberbauer, A.M. Owner Reports of Attention, Activity, and Impulsivity in Dogs: A Replication Study. Behav. Brain Funct. 2010, 6, 1. [Google Scholar] [CrossRef] [Green Version]
  10. Piotti, P.; Satchell, L.P.; Lockhart, T.S. Impulsivity and Behaviour Problems in Dogs: A Reinforcement Sensitivity Theory Perspective. Behav. Process. 2018, 151, 104–110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Sonuga-Barke, E.J.S. Causal Models of Attention-Deficit/Hyperactivity Disorder: From Common Simple Deficits to Multiple Developmental Pathways. Biol. Psychiatry 2005, 57, 1231–1238. [Google Scholar] [CrossRef] [PubMed]
  12. Del Campo, N.; Chamberlain, S.R.; Sahakian, B.J.; Robbins, T.W. The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder. Biol. Psychiatry 2011, 69, e145–e157. [Google Scholar] [CrossRef]
  13. Cho, H.S.; Baek, D.J.; Baek, S.S. Effect of Exercise on Hyperactivity, Impulsivity and Dopamine D2 Receptor Expression in the Substantia Nigra and Striatum of Spontaneous Hypertensive Rats. J. Exerc. Nutr. Biochem. 2014, 18, 379–384. [Google Scholar] [CrossRef] [PubMed]
  14. Mogavero, F.; Jager, A.; Glennon, J.C. Clock Genes, ADHD and Aggression. Neurosci. Biobehav. Rev. 2018, 91, 51–68. [Google Scholar] [CrossRef] [PubMed]
  15. Mü ller Smith, K.; Daly, M.; Fischer, M.; Yiannoutsos, C.T.; Bauer, L.; Barkley, R.; Navia, B.A. Association of the Dopamine Beta Hydroxylase Gene with Attention Deficit Hyperactivity Disorder: Genetic Analysis of the Milwaukee Longitudinal Study. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2003, 119, 77–85. [Google Scholar] [CrossRef] [PubMed]
  16. Luescher, U.A. Hyperkinesis in Dogs: Six Case Reports. Can. Vet. J. 1993, 34, 368–370. [Google Scholar] [PubMed]
  17. Piturru, P. Methylphenidate Use in Dogs with Attention Deficit Hyperactivity Disorder (ADHD). A Case Report of a Weimaraner Bitch. Tierarztl. Prax. Ausgabe K Kleintiere-Heimtiere 2014, 42, 111–116. [Google Scholar] [CrossRef]
  18. Lowe, N.; Kirley, A.; Hawi, Z.; Sham, P.; Wickham, H.; Kratochvil, C.J.; Smith, S.D.; Lee, S.Y.; Levy, F.; Kent, L.; et al. Joint Analysis of the DRD5 Marker Concludes Association with Attention-Deficit/Hyperactivity Disorder Confined to the Predominantly Inattentive and Combined Subtypes. Am. J. Hum. Genet. 2004, 74, 348–356. [Google Scholar] [CrossRef] [Green Version]
  19. Kubinyi, E.; Vas, J.; Hejjas, K.; Ronai, Z.; Brúder, I.; Turcsán, B.; Sasvari-Szekely, M.; Miklósi, Á. Polymorphism in the Tyrosine Hydroxylase (TH) Gene Is Associated with Activity-Impulsivity in German Shepherd Dogs. PLoS ONE 2012, 7, e30271. [Google Scholar] [CrossRef] [Green Version]
  20. Hejjas, K.; Vas, J.; Topal, J.; Szantai, E.; Ronai, Z.; Szekely, A.; Kubinyi, E.; Horvath, Z.; Sasvari-Szekely, M.; Miklosi, A. Association of Polymorphisms in the Dopamine D4 Receptor Gene and the Activity-Impulsivity Endophenotype in Dogs. Anim. Genet. 2007, 38, 629–633. [Google Scholar] [CrossRef]
  21. Bolaños, C.A.; Willey, M.D.; Maffeo, M.L.; Powers, K.D.; Kinka, D.W.; Grausam, K.B.; Henderson, R.P. Antidepressant Treatment Can Normalize Adult Behavioral Deficits Induced by Early-Life Exposure to Methylphenidate. Biol. Psychiatry 2008, 63, 309–316. [Google Scholar] [CrossRef]
  22. Neil, R.; Carlson, B. Physiology of Behavior, 13th ed.; Pearson Education: Essex, UK, 2022. [Google Scholar]
  23. Quist, J.F.; Barr, C.L.; Schachar, R.; Roberts, W.; Malone, M.; Tannock, R.; Basile, V.S.; Beitchman, J.; Kennedy, J.L. The Serotonin 5-HT1B Receptor Gene and Attention Deficit Hyperactivity Disorder. Mol. Psychiatry 2003, 8, 98–102. [Google Scholar] [CrossRef] [Green Version]
  24. Banerjee, E.; Nandagopal, K. Does Serotonin Deficit Mediate Susceptibility to ADHD? Neurochem. Int. 2015, 82, 52–68. [Google Scholar] [CrossRef]
  25. Bleuer-Elsner, S.; Muller, G.; Beata, C.; Zamansky, A.; Marlois, N. Effect of Fluoxetine at a Dosage of 2-4 Mg/Kg Daily in Dogs Exhibiting Hypersensitivity-Hyperactivity Syndrome, a Retrospective Study. J. Vet. Behav. 2021, 44, 25–31. [Google Scholar] [CrossRef]
  26. Masson, S.; Gaultier, E. Retrospective Study on Hypersensitivity-Hyperactivity Syndrome in Dogs: Long-Term Outcome of High Dose Fluoxetine Treatment and Proposal of a Clinical Score. Dog Behav. 2018, 4, 15–32. [Google Scholar] [CrossRef]
  27. Lunõ, I.; Rosado, B.; Palacio, J.; Villegas, A.; González-Martínez, Á.; Garciá-Belenguer, S. Hyperactivity in a Weimaraner Dog. Dog Behav. 2015, 1, 32–40. [Google Scholar] [CrossRef]
  28. Barkley, R.A. Behavioral Inhibition, Sustained Attention, and Executive Functions: Constructing a Unifying Theory of ADHD. Psychol. Bull. 1997, 121, 65–94. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Coleman, M. Serotonin Concentrations in Whole Blood of Hyperactive Children. J. Pediatr. 1971, 78, 985–990. [Google Scholar] [CrossRef]
  30. Spivak, B.; Vered, Y.; Yoran-Hegesh, R.; Averbuch, E.; Mester, R.; Graf, E.; Weizman, A. Circulatory Levels of Catecholamines, Serotonin and Lipids in Attention Deficit Hyperactivity Disorder. Acta Psychiatr. Scand. 1999, 99, 300–304. [Google Scholar] [CrossRef]
  31. Lombroso, P.J.; Quist, J.F.; Kennedy, J.L. Genetics of Childhood Disorders: XXIII. ADHD, Part 7: The Serotonin System. J. Am. Acad. Child Adolesc. Psychiatry 2001, 40, 253–256. [Google Scholar]
  32. Wright, H.F.; Mills, D.S.; Pollux, P.M.J. Behavioural and Physiological Correlates of Impulsivity in the Domestic Dog (Canis familiaris). Physiol. Behav. 2012, 105, 676–682. [Google Scholar] [CrossRef] [Green Version]
  33. Rosado, B.; García-Belenguer, S.; León, M.; Chacón, G.; Villegas, A.; Palacio, J. Blood Concentrations of Serotonin, Cortisol and Dehydroepiandrosterone in Aggressive Dogs. Appl. Anim. Behav. Sci. 2010, 123, 124–130. [Google Scholar] [CrossRef]
  34. León, M.; Rosado, B.; García-Belenguer, S.; Chacón, G.; Villegas, A.; Palacio, J. Assessment of Serotonin in Serum, Plasma, and Platelets of Aggressive Dogs. J. Vet. Behav. Clin. Appl. Res. 2012, 7, 348–352. [Google Scholar] [CrossRef]
  35. Rosado, B.; García-Belenguer, S.; Palacio, J.; Chacón, G.; Villegas, A.; Alcalde, A.I. Serotonin Transporter Activity in Platelets and Canine Aggression. Vet. J. 2010, 186, 104–105. [Google Scholar] [CrossRef]
  36. Amat, M.; Le Brech, S.; Camps, T.; Torrente, C.; Mariotti, V.M.; Ruiz, J.L.; Manteca, X. Differences in Serotonin Serum Concentration between Aggressive English Cocker Spaniels and Aggressive Dogs of Other Breeds. J. Vet. Behav. Clin. Appl. Res. 2013, 8, 19–25. [Google Scholar] [CrossRef]
  37. Hoppe, N.; Bininda-Emonds, O.R.P.; Gansloßer, U. Correlates of Attention Deficit Hyperactivity Disorder (ADHD)-Like Behavior in Domestic Dogs: First Results from a Questionnaire-Based Study. Vet. Med.–Open J. 2017, 2, 95–131. [Google Scholar] [CrossRef]
  38. Serpell, J.A.; Hsu, Y. Development and Validation of a Novel Method for Evaluating Behavior and Temperament in Guide Dogs. Appl. Anim. Behav. Sci. 2001, 72, 347–364. [Google Scholar] [CrossRef]
  39. Duffy, D.L.; Hsu, Y.; Serpell, J.A. Breed Differences in Canine Aggression. Appl. Anim. Behav. Sci. 2008, 114, 441–460. [Google Scholar] [CrossRef]
  40. Serpell, J.A.; Hsu, Y. Effects of Breed, Sex, and Neuter Status on Trainability in Dogs. Anthrozoös 2005, 18, 196–207. [Google Scholar] [CrossRef] [Green Version]
  41. Wright, H.F.; Mills, D.S.; Pollux, P.M.J. Development and Validation of a Psychometric Tool for Assessing Impulsivity in the Domestic Dog (Canis familiaris). Int. J. Comp. Psychol. 2011, 24, 210–225. [Google Scholar] [CrossRef]
  42. Riemer, S.; Mills, D.S.; Wright, H. Impulsive for Life? The Nature of Long-Term Impulsivity in Domestic Dogs. Anim. Cogn. 2014, 17, 815–819. [Google Scholar] [CrossRef] [Green Version]
  43. Crockett, M.J.; Clark, L.; Robbins, T.W. Reconciling the Role of Serotonin in Behavioral Inhibition and Aversion: Acute Tryptophan Depletion Abolishes Punishment-Induced Inhibition in Humans. J. Neurosci. 2009, 29, 11993–11999. [Google Scholar] [CrossRef] [Green Version]
  44. Baumann, M.H.; Williams, Z.; Zolkowska, D.; Rothman, R.B. Serotonin (5-HT) Precursor Loading with 5-Hydroxy-l-Tryptophan (5-HTP) Reduces Locomotor Activation Produced by (+)-Amphetamine in the Rat. Drug Alcohol Depend. 2011, 114, 147–152. [Google Scholar] [CrossRef] [Green Version]
  45. Kabuki, Y.; Yamane, H.; Hamasu, K.; Furuse, M. Different Locomotor Activities and Monoamine Levels in the Brains of Djungarian Hamsters (D. sungorus) and Roborovskii Hamsters (D. roborovskii). Exp. Anim. 2008, 57, 447–452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Takahashi, H.; Takada, Y.; Urano, T.; Takada, A. 5-HT4 Receptors in the Hippocampus Modulate Rat Locomotor Activity. Hippocampus 2002, 12, 304–310. [Google Scholar] [CrossRef]
  47. Hechtman, L. Developmental, Neurobiological, and Psychosocial Aspects of Hyperactivity, Impulsivity, and Inattention. Child Adolesc. Psychiatry 1991, 318–330. [Google Scholar]
  48. Peremans, K.; Audenaert, K.; Coopman, F.; Blanckaert, P.; Jacobs, F.; Otte, A.; Verschooten, F.; Van Bree, H.; Van Heeringen, K.; Mertens, J.; et al. Estimates of Regional Cerebral Blood Flow and 5-HT2A Receptor Density in Impulsive, Aggressive Dogs with 99mTc-ECD and 123I-5-I-R91150. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1538–1546. [Google Scholar] [CrossRef] [PubMed]
  49. Biederman, J.; Faraone, S.V.; Spencer, T.; Wilens, T.; Norman, D.; Lapey, K.A.; Mick, E.; Lehman, B.K.; Doyle, A. Patterns of Psychiatric Comorbidity, Cognition, and Psychosocial Functioning in Adults with Attention Deficit Hyperactivity Disorder. Am. J. Psychiatry 1993, 150, 1792–1798. [Google Scholar] [CrossRef] [PubMed]
  50. Sobanski, E. Psychiatric Comorbidity in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256, i26–i31. [Google Scholar] [CrossRef]
  51. Rucklidge, J.J.; Downs-Woolley, M.; Taylor, M.; Brown, J.A.; Harrow, S.E. Psychiatric Comorbidities in a New Zealand Sample of Adults with ADHD. J. Atten. Disord. 2016, 20, 1030–1038. [Google Scholar] [CrossRef] [PubMed]
  52. Mikkola, S.; Salonen, M.; Puurunen, J.; Hakanen, E.; Sulkama, S.; Araujo, C.; Lohi, H. Aggressive Behaviour Is Affected by Demographic, Environmental and Behavioural Factors in Purebred Dogs. Sci. Rep. 2021, 11, 9433. [Google Scholar] [CrossRef]
  53. Deakin, J.F.W.; Graeff, F.G. 5-HT and Mechanisms of Defence. Author’s Response. J. Psychopharmacol. 1991, 5, 339–341. [Google Scholar] [CrossRef] [PubMed]
  54. Deakin, J.F.W. The Origins of “5-HT and Mechanisms of Defence” by Deakin and Graeff: A Personal Perspective. J. Psychopharmacol. 2013, 27, 1084–1089. [Google Scholar] [CrossRef] [PubMed]
  55. Corchs, F.; Nutt, D.J.; Hince, D.A.; Davies, S.J.C.; Bernik, M.; Hood, S.D. Evidence for Serotonin Function as a Neurochemical Difference between Fear and Anxiety Disorders in Humans? J. Psychopharmacol. 2015, 29, 1061–1069. [Google Scholar] [CrossRef] [PubMed]
  56. Van Ameringen, M.; Mancini, C.; Oakman, J.M.; Farvolden, P. Selective Serotonin Reuptake Inhibitors in the Treatment of Social Phobia: The Emerging Gold Standard. CNS Drugs 1999, 11, 307–315. [Google Scholar] [CrossRef]
  57. Den Boer, J.A.; Bosker, F.J.; Slaap, B.R. Serotonergic Drugs in the Treatment of Depressive and Anxiety Disorders. Hum. Psychopharmacol. 2000, 15, 315–336. [Google Scholar] [CrossRef]
  58. Seksel, K.; Lindeman, M.J. Use of Clomipramine in Treatment of Obsessive-Compulsive Disorder, Separation Anxiety and Noise Phobia in Dogs: A Preliminary, Clinical Study. Aust. Vet. J. 2001, 79, 252–256. [Google Scholar] [CrossRef]
  59. Ibáñez, M.; Anzola, B. Use of Fluoxetine, Diazepam, and Behavior Modification as Therapy for Treatment of Anxiety-Related Disorders in Dogs. J. Vet. Behav. Clin. Appl. Res. 2009, 4, 223–229. [Google Scholar] [CrossRef]
  60. Shannon, C.; Schwandt, M.L.; Champoux, M.; Shoaf, S.E.; Suomi, S.J.; Linnoila, M.; Higley, J.D. Maternal Absence and Stability of Individual Differences in CSF 5-HIAA Concentrations in Rhesus Monkey Infants. Am. J. Psychiatry 2005, 162, 1658–1664. [Google Scholar] [CrossRef] [Green Version]
  61. Kiser, D.; SteemerS, B.; Branchi, I.; Homberg, J.R. The Reciprocal Interaction between Serotonin and Social Behaviour. Neurosci. Biobehav. Rev. 2012, 36, 786–798. [Google Scholar] [CrossRef]
  62. Kinnally, E.L.; Capitanio, J.P.; Leibel, R.; Deng, L.; Leduc, C.; Haghighi, F.; Mann, J.J. Epigenetic Regulation of Serotonin Transporter Expression and Behavior in Infant Rhesus Macaques. Genes Brain Behav. 2010, 9, 575–582. [Google Scholar] [CrossRef] [Green Version]
  63. Hejjas, K.; Vas, J.; Kubinyi, E.; Sasvari-Szekely, M.; Miklosi, A.; Ronai, Z. Novel Repeat Polymorphisms of the Dopaminergic Neurotransmitter Genes among Dogs and Wolves. Mamm. Genome 2007, 18, 871–879. [Google Scholar] [CrossRef] [PubMed]
  64. Hejjas, K.; Kubinyi, E.; Ronai, Z.; Szekely, A.; Vas, J.; Miklósi, Á.; Sasvari-Szekely, M.; Kereszturi, E. Molecular and Behavioral Analysis of the Intron 2 Repeat Polymorphism in the Canine Dopamine D4 Receptor Gene. Genes Brain Behav. 2009, 8, 330–336. [Google Scholar] [CrossRef]
  65. Sulkama, S.; Puurunen, J.; Salonen, M.; Mikkola, S.; Hakanen, E.; Araujo, C.; Lohi, H. Canine Hyperactivity, Impulsivity, and Inattention Share Similar Demographic Risk Factors and Behavioural Comorbidities with Human ADHD. Transl. Psychiatry 2021, 11, 501. [Google Scholar] [CrossRef]
  66. Zink, M.C.; Farhoody, P.; Elser, S.E.; Ruffini, L.D.; Gibbons, T.A.; Rieger, R.H. Evaluation of the Risk and Age of Onset of Cancer and Behavioral Disorders in Gonadectomized Vizslas. J. Am. Vet. Med. Assoc. 2014, 244, 309–319. [Google Scholar] [CrossRef]
  67. Fadel, F.R.; Driscoll, P.; Pilot, M.; Wright, H.; Zulch, H.; Mills, D. Differences in Trait Impulsivity Indicate Diversification of Dog Breeds into Working and Show Lines. Sci. Rep. 2016, 6, 22162. [Google Scholar] [CrossRef] [Green Version]
  68. Jagoe, A.; Serpell, J. Owner Characteristics and Interactions and the Prevalence of Canine Behaviour Problems. Appl. Anim. Behav. Sci. 1996, 47, 31–42. [Google Scholar] [CrossRef]
  69. Serpell, J.A.; Duffy, D.L. Aspects of Juvenile and Adolescent Environment Predict Aggression and Fear in 12-Month-Old Guide Dogs. Front. Vet. Sci. 2016, 3, 49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Yang, J.; Langford, F.; Kiddie, J. Risk Factors for Aggressive Behaviour in Domestic Dogs (Canis familiaris), as Reported by Owners in Mainland China. Appl. Anim. Behav. Sci. 2021, 234, 105211. [Google Scholar] [CrossRef]
  71. Wipfli, B.M. Serotonin and Psychological Variables in the Relationship between Exercise and Mental Health; Arizona State University: Tempe, Arizona, 2008; Volume 69. [Google Scholar]
  72. Tiira, K.; Lohi, H. Early Life Experiences and Exercise Associate with Canine Anxieties. PLoS ONE 2015, 10, e0141907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Animals 13 01037 g001 550
Figure 1. Box diagrams of the serotonin and dopamine levels for the dogs with suspected diagnoses of being ADHD-like (vs. the control dogs) and the dogs with scores over and under the median for the different DIAS, Dog ARS, and C-BARQ traits.
Figure 1. Box diagrams of the serotonin and dopamine levels for the dogs with suspected diagnoses of being ADHD-like (vs. the control dogs) and the dogs with scores over and under the median for the different DIAS, Dog ARS, and C-BARQ traits.
Animals 13 01037 g001
Table
Table 1. ADHD-like symptoms.
Table 1. ADHD-like symptoms.
Attention Deficit Symptoms
Other things attract attention easily
Loses interest easily
Difficulty concentrating
Does not pay attention to someone speaking to him/her
Difficulty performing practiced tasks
Easily distracted
Hyperactivity-impulsivity
Difficulty maintaining stay
Barks endlessly
Fidgets or in constant motion
Excessive active play/running around
Reacts hastily/anticipates
Cannot wait
Noninhibited bite
Lack of safety
Lack of sleep during the day and frequent waking up and movement during the night
Aggressive displays
Modified version of the lists created by Bleuer-Elsner et al., Hoppe et al., Lit et al., and Vas et al. [8,9,25,37].
Table
Table 2. Descriptive analysis of the studied dog population according to ADHD-like clinical diagnosis.
Table 2. Descriptive analysis of the studied dog population according to ADHD-like clinical diagnosis.
VariableDescriptive Features
Total (n = 58)ADHD-Like (n = 36)Not ADHD-Like
(n = 22)
GenderDataData
Female29 (50%)16 (44.4%)13 (59.1%)
Male29 (50%)20 (55.6%)9 (40.9%)
Neutered
Yes42 (72.4%)28 (77.8%)14 (36.4%)
No16 (17.6%)8 (22.2%)8 (63.6%)
Age (mean, median, (S.D.), and range)48.2, 45, (33.9), and 7–15640.2, 34, (31.1), and 11–12161.2, 61, (35.0), and 7–156
Age at acquisition (mean, median, and (S.D.))6.1, 2, and (11.1)6.2, 2, and (13.3)5.9, 2, and (6.3)
Weight (mean, median, and (S.D.))21.4, 22, and (9.4)21.3, 21, and (8.4)21.7, 23, and (11.1)
Dog activity patterns
No activity54 (93.1%)34 (94.4%)20 (90.9%)
Agility/biking/marching/mushing/other4 (6.9%)2 (5.6%)2 (9.1%)
Dogs previously owned
None19 (32.8%)12 (33.3%)7 (31.8%)
One or more39 (67.2%)24 (66.7%)15 (68.2%)
Habitat
Rural19 (32.8%)11 (30.6%)9 (40.9%)
Urban39 (67.2%)25 (69.4%)13 (59.1%)
Table
Table 3. Mean serotonin and dopamine serum concentrations (ng/mL) of the dogs with suspected diagnoses for being ADHD-like (vs. the not ADHD-like dogs) and the dogs with scores over and under the median for the different DIAS, DOG ARS, and C-BARQ traits (different superscripts indicate significant differences). The mean scores obtained for the dogs with scores over and under the median for the different traits are provided, along with the standard deviations (SDs).
Table 3. Mean serotonin and dopamine serum concentrations (ng/mL) of the dogs with suspected diagnoses for being ADHD-like (vs. the not ADHD-like dogs) and the dogs with scores over and under the median for the different DIAS, DOG ARS, and C-BARQ traits (different superscripts indicate significant differences). The mean scores obtained for the dogs with scores over and under the median for the different traits are provided, along with the standard deviations (SDs).
Serum Serotonin Concentration (95% CI)Serum Dopamine Concentration (95% CI)Mean Score (SD)
ADHD-like
Yes311.91 (257.36–366.45) a55.49 (50.51–60.47) a
No477.06 (391.20–562.92) b68.68 (57,54–70,81) b
DIAS total score
Under median449.28 (376.98–521.59) a63.90 (54.66–73.14)0.46 (0.07)
Over median304.29 (240.75–367.83) b57.41 (51.49–63.39)0.73 (0.08)
DIAS behavioral regulation score
Under median428.56 (353.75–503.37) a63.99 (55.14–72.85)0.37 (0.10)
Over median321.18 (255.63–386.73) b57.04 (50.87–63.22)0.75 (0.11)
DIAS responsiveness score
Under median389.56 (315.02–464.10)64.32 (55.46–73.18)0.32 (0.08)
Over median364.01 (291.23–436.80)57.25 (50.57–63.92)0.65 (0.20)
DIAS aggression score
Under median414.08 (342.37–485.78) a63.16 (53.60–72.71)0.58 (0.11)
Over median334.82 (259.17–410.47) b57.57 (51.66–63.49)0.81 (0.08)
Dog ARS activity-impulsivity score
Under median432.10 (360.58–503.62) a64.14 (55.52–72.77) a2.90 (1.70)
Over median303.04 (240.17–365.91) b56.57 (50.38–62.77) b10.1 (3.61)
Dog ARS inattention score
Under median402.22 (328.84–475.59)60.28 (52.01–68.56)4.16 (3.14)
Over median347.45 (275.34–419.55)61.20 (53.76–68.64)14.77 (4.15)
C-BARQ trainability
Under median381.53 (310.88–452.18)60.48 (54.46–66.51)2.15 (0.36)
Over median371.32 (293.90–448.74)61.04 (50.44–71.64)3.13 (0.30)
C-BARQ stranger-directed aggression
Under median394.32 (331.29–457.34)62.75 (54.16–71.350.04 (0.07)
Over median356.56 (271.37–441.75)58.25 (51.71–64.79)0.98 (0.81)
C-BARQ owner-directed aggression
Under median401.08 (344.04–458.13) a58.98 (53.04–64.91)0.02 (0.07)
Over median303.90 (192.38–415.42) b67.35 (52.94–81.76)0.62 (0.55)
C-BARQ dog-directed aggression
Under median394.89 (327.73–462.05)61.66 (53.78–69.53)0.15 (0.03)
Over median348.81 (267.45–430.17)59.39 (51.76–67.02)1.56 (0.91)
C-BARQ dog-directed fear
Under median449.32 (378.88–519.75) a57.36 (51.96–62.75)0.21 (0.24)
Over median318.03 (250.60–385.99) b63.71 (54.44–72.99)1.38 (0.78)
C-BARQ rivalry
Under median421.10 (338.25–503.94)61.97 (52.81–71.13)0.02 (0.08)
Over median331.96 (258.93–404.99)55.61 (50.91–60.31)0.94 (0.54)
C-BARQ chasing
Under median414.29 (52.96–70.87)61.92 (52.96–70.87)0.66 (0.55)
Over median344.29 (52.64–66.80)59.72 (52.64–66.80)2.78 (0.78)
C-BARQ stranger-directed fear
Under median397.87 (336.00–459.75)62.76 (54.40–71.12)0.05 (0.10)
Over median344.20 (253.34–435.06)57.34 (52.59–62.08)1.58 (1.01)
C-BARQ nonsocial fear
Under median438.03 (366.61–509.45) a61.49 (54.85–68.13)0.27 (0.19)
Over median319.77 (251.00–388.54) b59.91 (50.79–69.03)1.54 (0.77)
C-BARG separation-related problems
Under median387.91 (308.59–467.23)63.22 (54.84–71.60)0.16 (0.17)
Over median366.43 (297.99–434.87)58.30 (50.94–65.67)1.18 (0.48)
C-BARQ sensitivity
Under median407.42 (340.31–474.52)60.95 (54.84–67.05)0.23 (0.21)
Over median321.65 (246.73–396.58)60.26 (48.60–71.92)1.34 (0.70)
C-BARQ excitability
Under median414.16 (346.02–482.31)62.92 (54.08–71.76)1.09 (0.36)
Over median336.64 (260.02–413.27)58.24 (51.84–64.64)2.39 (0.50)
C-BARQ attachment
Under median419.28 (344.33–494.23)59.31 (50.48–68.14)1.36 (0.45)
Over median334.29 (265.56–403.02)62.17 (55.41–68.94)3.08 (0.62)
C-BARQ energy
Under median392.08 (326.48–457.69)65.62 (57.16–74.08) a2.08 (1.12)
Over median354.84 (270.15–439.54)53.81 (49.13–58.49) b3.81 (0.72)
Table
Table 4. Results of Lasso regression models for the effects of serotonin and dopamine serum concentrations in dogs on ADHD-like diagnosis (yes/no) and scores (over and under the median) for the different DIAS and DOG ARS traits.
Table 4. Results of Lasso regression models for the effects of serotonin and dopamine serum concentrations in dogs on ADHD-like diagnosis (yes/no) and scores (over and under the median) for the different DIAS and DOG ARS traits.
CoeffcientsADHD-Like
R2 = 0.4698		DIAS Total
R2 = 0.2119		DIAS BR
R2 = 0.2134		DIAS A
R2 = 0.1716		Dog ARS AI
R2 = 0.08921
Serotonine−0.0010−0.0007−0.0005−0.0005−0.0004
Dopamine−0.0057−0.0013
Gender
Male *		0.06090.04110.14270.0207-
Neutered
Entire **		0.06300.02300.0317--
Age−0.0025-−0.0002--
Age at acquisition --
Weight-----
Dog activity pattern
***		---−0.3389-
First dog---−0.0180-
* Female is the base; ** neutered is the base; *** no activity is the base.
Table
Table 5. Results of Lasso regression models for the effects of serotonin and dopamine serum concentrations in dogs on scores (over and under the median) for the different C-BARQ traits.
Table 5. Results of Lasso regression models for the effects of serotonin and dopamine serum concentrations in dogs on scores (over and under the median) for the different C-BARQ traits.
CoeffcientsDog-Directed Fear
R2 = 0.4380		Rivalry
R2 = 0.25117		Nonsocial Fear
R2 = 0.1399		Sensitivity
R2 = 0.2143		Attachment
R2 = 0.2284		Energy
R2 = 0.2638
Serotonine−0.0006−0.0006−0.0004−0.0001−0.0005
Dopamine −0.0044
Gender
Male *		0.3686−0.0129 0.1800
Neutered
Entire **		0.10950.1564
Age −0.0046
Age at acquisition−0.0908 −0.1593
Weight −0.01070.0028
Dog activity pattern
***		 −0.0406
First dog0.2281−0.2629 −0.2646
* Female is the base; ** neutered is the base; *** no activity is the base.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

González-Martínez, Á.; Muñiz de Miguel, S.; Graña, N.; Costas, X.; Diéguez, F.J. Serotonin and Dopamine Blood Levels in ADHD-Like Dogs. Animals 2023, 13, 1037. https://doi.org/10.3390/ani13061037

AMA Style

González-Martínez Á, Muñiz de Miguel S, Graña N, Costas X, Diéguez FJ. Serotonin and Dopamine Blood Levels in ADHD-Like Dogs. Animals. 2023; 13(6):1037. https://doi.org/10.3390/ani13061037

Chicago/Turabian Style

González-Martínez, Ángela, Susana Muñiz de Miguel, Noemi Graña, Xiana Costas, and Francisco Javier Diéguez. 2023. "Serotonin and Dopamine Blood Levels in ADHD-Like Dogs" Animals 13, no. 6: 1037. https://doi.org/10.3390/ani13061037

APA Style

González-Martínez, Á., Muñiz de Miguel, S., Graña, N., Costas, X., & Diéguez, F. J. (2023). Serotonin and Dopamine Blood Levels in ADHD-Like Dogs. Animals, 13(6), 1037. https://doi.org/10.3390/ani13061037

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop